The immunotherapy of solid cancers based on cloning the genes encoding tumor-rejection antigens

Annual Review of Medicine

Volumn 47, Issue , 1996, Pages 481-491

  Rosenberg, Steven A ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

gp100; Interleukin 2; Lymphocytes; MART 1; Melanoma

Indexed keywords

ANTIGEN; CANCER VACCINE; GENE PRODUCT; INTERLEUKIN 2; TUMOR ANTIGEN;

ACTIVE IMMUNIZATION; ADOPTIVE TRANSFER; ANTINEOPLASTIC ACTIVITY; BREAST CANCER; CANCER; CANCER IMMUNOTHERAPY; CELL ISOLATION; CELLULAR IMMUNITY; EXPRESSION VECTOR; GENE; HUMAN; MELANOMA; METASTASIS; MOLECULAR CLONING; MOLECULAR RECOGNITION; OVARY CANCER; PRIORITY JOURNAL; REVIEW; TUMOR ASSOCIATED LEUKOCYTE; TUMOR REGRESSION; VIRUS;

ANIMALS; ANTIGENS, NEOPLASM; BREAST NEOPLASMS; CLONING, MOLECULAR; FEMALE; HUMANS; IMMUNOTHERAPY; IMMUNOTHERAPY, ADOPTIVE; LYMPHOCYTES, TUMOR-INFILTRATING; MALE; NEOPLASMS; OVARIAN NEOPLASMS; VACCINES, SYNTHETIC;

EID: 0029988368     PISSN: 00664219     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.med.47.1.481     Document Type: Review

References (38)

1. Marincola FM, Rosenberg SA. 1995. Melanoma. In Biologic Therapy of Cancer, ed. VT De Vita, S Hellman, S A Rosenberg, p.250-52. Philadelphia: Lippincott. 2nd ed.
2. Foon KA. 1995. Hairy cell leukemia, chronic myelogenousleukemia, and myeloproliferative disorders. In Biologic Therapy of Cancer, ed. VT De Vita, S Hellman, SA Rosenberg, p. 365-73. Philadelphia: Lippincott. 2nd ed.
3. Boon T. 1993. Tumor antigens reocgnized by cytolytic T lymphocytes present perspectives for specific immunotherapy. Int. J. Cancer 54:177-80
4. Rosenberg SA. 1995. A new perspective: the development of new cancer therapies based on the molecular identification of cancer regression antigens. Cancer J. Sci. Am. 1:89-100
5. Rosenberg SA, Lotze MT, Muul LM, et al. 1985. Observations on the systemic administration of autologous lymphokine-activated killer cells and recombinant interleukin-2 to patients with metastatic cancer. N. Engl. J. Med. 313:1485-92
6. Lotze MT, Chang AE, Seipp CA, et al. 1986. High dose recombinant interleukin-2 in the treatment of patients with disseminated cancer: responses, treatment related morbidity and histologic findings. J. Am. Med. Assoc. 256:3117-24
7. Lotze MT, Rosenberg SA. 1987. Interleukin-2 therapy for disseminated cancer. JAMA 257:1730-31
8. Rosenberg SA, Yang JC, Topalian SL, et al. 1994. Treatment of 283 consecutive patients with metastatic melanoma or renal cell cancer using high-dose bolus interleukin-2. JAMA 271:907-13
9. Itoh K, Tilden AB, Balch CM. 1986. Interleukin-2 activation of cytotoxic T-lymphocytes infiltrating into human metastatic melanomas. Cancer Res. 46:3011-17
10. Muul LM, Spiess PJ, Director EP, Rosenberg SA. 1987. Identification of specific cytolytic immune responses against autologous tumor in humans bearing malignant melanoma. J. Immunol. 138:989-95
11. Topalian SL, Solomon D, Rosenberg SA. 1989. Tumor-specific cytolysis by lymphocytes infiltrating human melanomas. J. Immunol. 142:3714-25
12. Horn SS, Topalian SL, Simoni ST, et al. 1991. Common expression of melanoma tumor-associated antigens recognized by human tumor-infiltrating lymphocytes: analysis by human lymphocyte antigen restriction. J. Immunother. 10:153-64
13. Darrow TL, Slingluff CL, Seigler HF. 1989. The role of class I antigens in recognition of melanoma cells by tumor-specific cytotoxic T lymphocytes: evidence for shared tumor antigens. J. Immunol. 142: 153-64
14. Kawakami Y, Zakut R, Topalian SL, et al. 1992. Shared human melanoma antigens. Recognition by tumor infiltrating lymphocytes in HLA-A2.1 transfected melanomas. J. Immunol. 148:638-43
15. O'Neil BH, Kawakami Y, Restifo NP, et al. 1993. Detection of shared MHC-restricted human melanoma antigens after vaccinia virus-mediated transduction of genes coding for HLA. J. Immunol 151:1410-18
16. Topalian SL, Hom SS, Kawakami Y, et al. 1992. Recognition of shared melanoma antigens by human tumor infiltrating lymphocytes. J. Immunother. 12:203-6
17. Kawakami Y, Nishimura I, Restifo NP, et al. 1993. T-cell recognition of human melanoma antigens. J. Immunother. 14:88-93
18. Anichini A, Maccalli C, Mortarini R, et al. 1993. Melanoma cells and normal melanocytes share antigens recognized by HLA-A2 restricted cytotoxic T cell clones from melanoma patients. J. Exp. Med. 177: 989-98
19. Rosenberg SA, Packard BS, Aebersold PM, et al. 1988. Use of tumor infiltrating lymphocytes and interleukin-2 in the immunotherapy of patients with metastatic melanoma. Preliminary report. N. Engl. J. Med. 319:1676-80
20. Rosenberg SA, Yannelli JR, Yang JC, et al. 1994. Treatment of patients with metastatic melanoma using autologous tumor-infiltrating lymphocytes and interleukin-2. J. Natl. Cancer Inst. 86:1159-66
21. Van der Bruggen P, Traversari C, Chomez P, et al. 1991. A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. Science 254:1643-47
22. Kawakami Y, Eliyahu S, Delgado CH, et al. 1994. Identification of a human melanoma antigen recognized by tumor infiltrating lymphocytes associated with in vivo tumor rejection. Proc. Natl. Acad. Sci. USA 91: 6458-62
23. Kawakami Y, Eliyahu S, Delgado CH, et al. 1994. Cloning of the gene coding for a shared human melanoma antigen recognized by autologous T cells infiltrating into tumor. Proc. Natl. Acad.Sci. USA 91: 3515-19
24. Robbins PF, El-Gamil M, Kawakami Y, et al. 1994. Recognition of tyrosinase by tumor infiltrating lymphocytes from a patient responding to immunotherapy. Cancer Res. 54:3124-26
25. + T cells specifically recognize a shared melanoma-associated antigen encoded by the tyrosinase gene. Proc. Natl. Acad. Sci. USA 91:9461-65
26. Robbins PF, El-Gamil M, Li Y, et al. 1995. Cloning of a new gene encoding an antigen recognized by melanoma-specific HLA-A24-restricted tumor-infiltrating lymphocytes. J. Immunol. 154:5944-50
27. Wang RF, Robbins PF, Kawakami Y, et al. 1995. Identification of a gene encoding a melanoma tumor antigen recognized by HLA-A31-restricted tumor-infiltrating lymphocytes. J. Exp. Med. 181:799-804
28. Kawakami Y, Eliyahu S, Jennings C, et al. 1995. Recognition of multiple epitopes in the human melanoma antigen gp100 by tumor infiltrating T-lymphocytes associated with in vivo tumor regression. J. Immunol. 154:3461-68
29. Kawakami Y, Eliyahu S, Sakaguchi K, et al. 1994. Identification of the immunodominant peptides of the MART-1 human melanoma antigen recognized by the majority of HLA-A2 restricted tumor infiltrating lymphocytes. J. Exp. Med. 180:347-52
30. Kang S, Kawakami Y, Wang R, et al. 1995. Identification of a tyrosinase epitope recognized by HLA-A24 restricted tumor infiltrating lymphocytes. Cancer Res. 155: 1343-48
31. Rivoltini L, Kawakami Y, Sakaguchi K, et al. 1995. Induction of tumor-reactive CTL from peripheral blood and tumor-infiltrating lymphocytes of melanoma patients by in vitro stimulation with an immunodominant peptide of the human melanoma antigen MART-1. J. Immunol. 154:2257-65
32. Shilyansky J, Nishimura MI, Yannelli JR, et al. 1994. T cell receptor usage by melanoma specific clonal and highly oligoclonal tumor infiltrating lymphocyte lines. Proc. Natl. Acad. Sci. USA 91:2829-33
33. Cole DJ, Weil DP, Shamamian P, et al. 1994. Identification of MART-I specific T-cell receptors: T-cells utilizing distinct T-cell receptor variable and joining regions recognize the same tumor epitope. Cancer Res. 54:5265-68
34. Nishimura MI, Kawakami Y, Charmley P, et al. 1994. T cell receptor repertoire in tumor infiltrating lymphocytes. Analysis of melanoma specific long term lines. J. Immunother. 16:85-94
35. Cole DJ, Weil DP, Shilyansky J, et al. 1995. Characterization of the functional specificity of a cloned T-cell receptor heterodimer recognizing the MART-1 melanoma antigen. Cancer Res. 55:748-52
36. Irvine KR, Rao RB, Rosenberg SA, Restifo NP. 1995. Cytokine enhancement of DNA immunization leads to treatment of established pulmonary metastases. J. Immunol. Submitted for publication
37. Bronte V, Tsung K, Rao J, et al. 1995. IL-2 enhances the function of recombinant poxvirus-based vaccines in the treatment of established pulmonary metastases. J. Immunol. 154:5282-92
38. Wang M, Bronte V, Chen PW, et al. 1995. Active immunotherapy of cancer with a non-replicating recombinant fowlpox virus encoding a model tumor-associated antigen. J. Immunol. 154:4685-92